TINTOMETER GMBH – Trademark Portfolio

Entity Type: 03

TINTOMETER GMBH holds 17 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 12 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 2 Nice Classification classes. Currently, 4 trademarks are registered and 2 are pending. Notable registered marks include EVO, BLAC, and LOVIBOND. The owner is based in DORTMUND.

SCHLEEFSTRASSE, 8A

DORTMUND 44287 , DE

17 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

TINTOMETER GMBH's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (12 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

1
Chemicals (11 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does TINTOMETER GMBH have?

TINTOMETER GMBH has 17 U.S. trademarks filed with the USPTO. Of these, 4 registered, 2 pending, 1 abandoned, 1 cancelled.

What trademark classes does TINTOMETER GMBH file in?

TINTOMETER GMBH files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 1 (Chemicals). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are TINTOMETER GMBH's most well-known trademarks?

TINTOMETER GMBH's registered trademark portfolio includes well-known marks such as EVO, BLAC, and LOVIBOND. These are among 4 currently registered trademarks in the portfolio.

What is TINTOMETER GMBH's trademark registration success rate?

TINTOMETER GMBH has a 67% trademark registration rate, with 4 out of 6 resolved applications resulting in successful registration. Currently, 2 applications are pending review.